NDC 58670-001 - Antiemetic Gastrokinetic PILERAN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58670-001
- Package NDCs from labels
- 58670-001-20
- Manufacturer
- Holliday-Scott S.A. | Ipca Laboratories Limited
- Effective date
- 2013-07-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METOCLOPRAMIDE HYDROCHLORIDE - Holliday-Scott S.A. | Ipca Laboratories Limited | Holliday-Scott S.A. | Ipca Laboratories Limited | 2013-07-18 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58670-001-20 | Antiemetic Gastrokinetic PILERAN | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 58670-001-20 | Antiemetic Gastrokinetic PILERAN | 20 mL in 1 BOTTLE, DROPPER | SOLUTION | 20 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METOCLOPRAMIDE HYDROCHLORIDE | ACTIVE INGREDIENT | W1792A2RVD | ANTIEMETIC GASTROKINETIC PILERAN (METOCLOPRAMIDE HYDROCHLORIDE) SOLUTION [HOLLIDAY-SCOTT S.A.] | 1 | |
| METOCLOPRAMIDE | ACTIVE MOIETY | L4YEB44I46 | ANTIEMETIC GASTROKINETIC PILERAN (METOCLOPRAMIDE HYDROCHLORIDE) SOLUTION [HOLLIDAY-SCOTT S.A.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | 5645a752-8868-4b51-8b59-48bb4276d763 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| METOCLOPRAMIDE | METOCLOPRAMIDE | HF Acquisition Co LLC, DBA HealthFirst | 4046830f-4b87-5e6e-e063-6394a90aeeb8 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Teva Pharmaceuticals USA, Inc. | e15905e0-e0f6-4c8b-ac19-59724d6c4bf0 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| GIMOTI | METOCLOPRAMIDE HYDROCHLORIDE | Evoke Pharma, Inc. | 95269b1f-779c-4ca0-9f86-e74e677f9900 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Reglan | METOCLOPRAMIDE HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | de55c133-eb08-4a35-91a2-5dc093027397 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Redpharm Drug | 49eb807b-fa34-3d84-e063-6394a90acfcf | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| metoclopramide hydrochloride | METOCLOPRAMIDE HYDROCHLORIDE | Chartwell RX, LLC | dc364325-dd39-4259-a348-3760eccdca4b | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | AvKARE | ff067ac5-6efc-3e86-e6d5-590b2779491c | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Northwind Health Company, LLC | f2b732ab-b859-7252-e053-2995a90af0d8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | NuCare Pharmaceuticals, Inc. | 4524146c-f588-083b-e063-6294a90ac977 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | NuCare Pharamceuticals, Inc. | 45250bbc-d079-c362-e063-6294a90a56e0 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| metoclopramide hydrochloride | METOCLOPRAMIDE HYDROCHLORIDE | Chartwell Governmental & Specialty RX, LLC. | c4ab34f2-25e6-47bd-9dde-1f4baf469f0d | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Bryant Ranch Prepack | 84ec68c1-efa0-4ed2-9fae-d0cc17b0a6b4 | 2025-11-05 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Medical Purchasing Solutions, LLC. | 41d9ee49-d434-5f9f-e063-6294a90afe0b | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | ProPharma Distribution | 3f2b17ea-c265-0cd4-e063-6294a90a9d88 | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | ATLANTIC BIOLOGICALS CORP. | 3ce3245f-7021-5135-e063-6394a90a7d95 | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Bryant Ranch Prepack | 67024bbc-65d1-428d-a807-46647038daf6 | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Bryant Ranch Prepack | 14114420-fee0-4850-b99e-cdb5f421cd33 | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Bryant Ranch Prepack | e34fea34-5fc5-4200-bc9d-f5e558023630 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.